Retina Consultants of Alabama P.C., Birmingham, Alabama; Department of Ophthalmology, University of Alabama-Birmingham, Birmingham, Alabama.
Retina Consultants of Alabama P.C., Birmingham, Alabama.
Ophthalmology. 2017 Sep;124(9):1377-1382. doi: 10.1016/j.ophtha.2017.03.053. Epub 2017 Apr 29.
Transvitreal and transscleral needle biopsy can result in complications including vitreous hemorrhage and retinal detachment. This study evaluated a technique using 25-gauge vitrectomy as an adjunct to needle biopsy immediately before brachytherapy to minimize these complications and preserve good visual acuity.
Retrospective, observational case series.
Fifty-seven consecutive eyes of 57 patients with treatment-naïve medium choroidal melanomas without extraocular extension from July 2012 through September 2015.
Fifty-seven consecutive eyes of 57 patients with a clinically diagnosed choroidal melanoma underwent complete 25-gauge posterior vitrectomy followed by transvitrector port fine-needle aspiration biopsy of the tumor immediately before implantation of a radioactive iodine 125 plaque as treatment for the tumor. Cytopathologic analysis was not performed on the tumor aspirates in this study.
Best-corrected postoperative visual acuity, postoperative complications of the reported technique, implantation tumor development, local tumor recurrence, presence of metastatic disease after surgery, and sufficiency of the tumor aspirates obtained by the reported technique for successful gene expression profile testing and prognostic classification.
Mean preoperative and postoperative visual acuities were similar (20/60 vs. 20/80, respectively). Mean tumor thickness was 5.0 mm (range, 2.5-10 mm) and mean tumor basal diameter was 13.1 mm (range, 7-22 mm). Only 1 of 57 eyes (1.8%) showed a transient vitreous hemorrhage, biopsy yield was 100% for genetic analysis, and no patients showed recurrence or implantation tumor at the vitrector site.
Combined 25-gauge posterior vitrectomy and 25-gauge trans-vitrector port needle aspiration biopsy immediately before brachytherapy is excellent for obtaining tumor aspirate for gene expression profiling while controlling for hemostasis, resulting in few complications.
经玻璃体和巩膜的针吸活检可导致包括玻璃体积血和视网膜脱离等并发症。本研究评估了一种技术,即在近距离放射治疗前使用 25 号玻璃体切割术作为辅助手段,以最小化这些并发症并保持良好的视力。
回顾性、观察性病例系列。
2012 年 7 月至 2015 年 9 月期间,57 例未经治疗的中脉络膜黑色素瘤且无眼外延伸的 57 例连续眼。
57 例未经治疗的中脉络膜黑色素瘤患者 57 只眼,在植入放射性碘 125 斑块治疗肿瘤之前,行完全 25 号后玻璃体切割术,然后经玻璃体端口细针抽吸活检肿瘤。本研究未对肿瘤抽吸物进行细胞病理学分析。
最佳矫正术后视力、报告技术的术后并发症、植入肿瘤发展、局部肿瘤复发、手术后转移性疾病的存在以及报告技术获得的肿瘤抽吸物是否足以进行成功的基因表达谱检测和预后分类。
平均术前和术后视力相似(分别为 20/60 和 20/80)。平均肿瘤厚度为 5.0mm(范围,2.5-10mm),平均肿瘤基底直径为 13.1mm(范围,7-22mm)。仅 1 只眼(1.8%)出现短暂性玻璃体积血,基因分析的活检产量为 100%,无患者出现复发或植入物在玻璃体部位。
在近距离放射治疗前联合使用 25 号后玻璃体切割术和 25 号经玻璃体端口针吸活检术,可极好地获得肿瘤抽吸物进行基因表达谱分析,同时控制止血,并发症少。